Chinese state-run outlet Global Times has put a label on what it says is the country's next wave of industrial upgrading: the "next new three" — artificial intelligence, robotics and innovative drugs.
The framing arrives in a Global Times piece carried internationally, including by The Manila Times and Indonesian outlet Tirto, which republished it as a Global Times release. That syndication footprint is itself part of the story: the phrase is being pushed outward to audiences well beyond China.
According to Global Times, the evidence is already visible in exported hardware. The report points to four-legged inspection robots working inside European nuclear power plants, and to robotic arms making coffee automatically for travelers at airports and transit hubs around the world. The article also gestures at smart AI applications, though the available excerpts cut off before detailing them.
The available source material is limited to that single syndicated article and its republications, so the specifics beyond those examples — targets, funding, company names, timelines — are not established here. What is clear is the positioning: Beijing-aligned media is grouping three high-value sectors under one banner and presenting them as the successor to whatever "new three" came before, with overseas deployments offered as proof the transition is underway rather than aspirational.
Readers should weigh the framing accordingly. Global Times is Chinese state-affiliated media, and a story naming a country's own strategic priorities doubles as messaging about them.
It matters because the sectors a government chooses to spotlight tend to be the ones that get capital, policy support and export muscle behind them — and AI, robotics and drug development are exactly the industries where Western firms are competing hardest.